Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient.
Mycoplasma hominis and Ureaplasma parvum are rare causes of severe and fatal infections. The diagnosis of infection with mycoplasma is dependent on clinical suspicion and microbiological diagnosis, and often relies on molecular methods that do not readily detect antibiotic resistance. This may be of increasing importance as illustrated in the case below.
MacKenzie
Colin R
CR
Institute of Medical Microbiology and Hospital Hygiene, University Hospital, Heinrich-Heine-University, Universitätsstraße 1, Düsseldorf, Germany. colin.mackenzie@uni-duesseldorf.de
Nischik
Nicole
N
Kram
Rainer
R
Krauspe
Rüdiger
R
Jäger
Marcus
M
Henrich
Birgit
B
D001170:Arthritis, Infectious / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects; D003428:Cross Infection / Q000175:diagnosis / Q000382:microbiology; D017809:Fatal Outcome; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009175:Mycoplasma Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*; D019535:Mycoplasma hominis / Q000187:drug effects / Q000235:genetics / Q000302:isolation & purification; D016869:Ureaplasma Infections / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*